| ≥1 piece |
Dasatinib (BMS-354825) is a novel, oral, potent, multi-targeted kinase inhibitor of Bcr-Abl and Src family kinases (SFK) and is a promising cancer therapeutic agent. Preclinical data indicate that dasatinib is 325-fold more potent than imatinib against cells expressing wild-type Bcr-Abl, and that dasatinib is active against 18 of 19 Bcr-Abl mutations known to cause imatinib resistance.
Chemical Name: N -(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)- 1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazole carboxamide monohydrate
CAS No.: [863127-77-9]
Molecular Formula: C 22H 26ClN7O2S.H 2 O
Molecular Weight: 506.02
Description:Off-white to pale yellow power .
Solubility: Insoluble in water, slightly soluble in methanol and ethanol.
Related substances:Any single impurities: NMT0.5%; Total impurities: NMT1.0%
Assay(HPLC):min 99%